Neeraj Agarwal, Professor of Medicine and a Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute (HCI), shared a post X:
“Congrats Michael Ong, Soumyajit Roy for oral Abstract 5002 at ASCO 25.
Real-world IRONMAN registry of mHSPC prostate cancer (n=1288 pts).
PSA<0.02 after 6-12 months of prescription had best prognosis (3-yr OS 92.7%)”
Title: Prognostic significance of PSA>0.2 after 6-12 months treatment for metastatic hormone-sensitive prostate cancer (mHSPC) intensified by androgen-receptor pathway inhibitors (ARPI): A multinational real-world analysis of the IRONMAN registry.
Journal: ASCO
Authors: Michael Ong, Soumyajit Roy, Kim Chi, Tanya Dorff, Sebastien Hotte, Alexander Wyatt, Lauren Howard, Karen Autio, Deborah Enting, Aurelius Omlin, Joaquin Mateo, Raymond McDermott, Ian Davis, Anders Bjartell, Laurel Cannon, Alyssa Chan-Cuzydlo, Philip Kantoff, Lorelei Mucci, Daniel George
More posts featuring Neeraj Agarwal on OncoDaily.
